
Sign up to save your podcasts
Or
How can community-based oncologists leverage the newest therapies for patients with heavily relapsed/refractory myeloma? Credit available for this activity expires: 4/25/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/991105?ecd=bdc_podcast_libsyn_mscpedu
4.3
2323 ratings
How can community-based oncologists leverage the newest therapies for patients with heavily relapsed/refractory myeloma? Credit available for this activity expires: 4/25/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/991105?ecd=bdc_podcast_libsyn_mscpedu
13 Listeners
316 Listeners
107 Listeners
171 Listeners
866 Listeners
498 Listeners
687 Listeners
18 Listeners
278 Listeners
256 Listeners
3,321 Listeners
135 Listeners
1,101 Listeners
8,002 Listeners
194 Listeners
60 Listeners
8 Listeners
428 Listeners
313 Listeners